Molecular Farming

The commonly used term ‘molecular farming’ describes the large‐scale production of valuable proteins in transgenic plants, including antibodies, vaccines, other pharmaceuticals and industrial proteins. Compared to traditionally used systems such as microbial cultures, plants offer many advantages with respect to economy, quality and safety. The organism or material into which the new genetic information is inserted is often referred to as the expression system since it serves as the system for “expressing” the new product. Plant molecular farming is currently being pursued to address either the increased demand for proteins that cannot be produced in sufficient quantities in either microbial or animal cell cultures, or as a means to produce proteins that cannot be expressed in microbial or animal cell cultures. Vaccines are another area of research in molecular farming. Early-stage clinical trials have been completed on customized, patient-specific vaccines for Non-Hodgkins Lymphoma. These plant-produced vaccines can be generated in 6 to 10 weeks, a much shorter time frame than conventional methods These plant-produced vaccines can be generated in 6 to 10 weeks, a much shorter time frame than conventional methods. As mentioned previously, edible vaccines, although enthusiastically discussed in recent years, have virtually been abandoned.

The benefits of molecular farming have been demonstrated over the last 15 years through the sustained efforts of a growing number of European research groups, many of which have participated in the COST action “Molecular farming: plants as a production platform for high value protein

Plant molecular farming (PMF) is a new branch of plant biotechnology, where plants are engineered to produce recombinant pharmaceutical and industrial proteins in large quantities. As an emerging subdivision of the biopharmaceutical industry, PMF is still trying to gain comparable social acceptance as the already established production systems that produce these high valued proteins in microbial, yeast, or mammalian expression systems. The products of pharming are recombinant proteins or their metabolic products. Recombinant proteins are most commonly produced using bacteria or yeast in a bioreactor, but pharming offers the advantage to the producer that it does not require expensive infrastructure, and production capacity can be quickly scaled to meet demand, at greatly reduced cost.

  • Scope of molecular farming
  • Production of Industrial enzymes and biodegradable plastics
  • Production of antibodies
  • Metabolic engineering for production of fatty acids, Industrial oils, Terpenoids and flavonoids
  • Growth and production kinetics of cell culture in shake flasks

Related Conference of Molecular Farming

May 09-10, 2018

11th World Congress on Cell & Tissue Science

Tokyo, Japan
May 14-15, 2018

World Congress on Cell and Structural Biology

Osaka Japan
May 21-23, 2018

6th International Conference on Integrative Biology

Barcelona, Spain
June 04-06, 2018

12th Annual Conference on Stem Cell and Regenerative Medicine

Prague, Czech Republic
July 2-3, 2018

4th International Conference on Bioscience

Vienna, Austria
July 10-11, 2018

22nd World Congress on Biotechnology

Bangkok, Thailand
July 23-24, 2018

Annual Biotechnology Congress

Vancouver, British Columbia, Canada
September 3-4, 2018

World Congress on Stem Cell Biology and Biobanking

Tokyo, Japan
September 10-11, 2018

22nd Global Biotechnology Congress

Stockholm, Sweden
September 17-18, 2018

6th Annual Congress on Biology and Medicine of Molecules

Abu Dhabi, UAE
September 17-18, 2018

International Conference on Foot and Ankle Surgeons

Dubai, UAE
September 19 - 20, 2018

2nd Annual summit on Cell Signaling and Cancer Therapy

Philadelphia, Pennsylvania, USA
September 19 - 20, 2018

2nd Annual summit on Cell Metabolism and Cytopathology

Philadelphia, Pennsylvania, USA
September 20-21, 2018

10th Tissue Repair and Regeneration Congress

Dubai, UAE
September 21-22, 2018

11th International Conference on Genomics and Pharmacogenomics

Philadelphia, Pennsylvania, USA
September 21-22, 2018

5th International Conference on Human Genetics and Genetic Diseases

Philadelphia, Pennsylvania, USA
October 24-25, 2018

24th Biotechnology Congress: Research & Innovations

Boston, Massachusetts, USA
October 24-25, 2018

Annual Congress on CRISPR-Cas9 Technology

Boston, USA
November 2-3, 2018

International Congress & Expo on Genomics and Bioinformatics

Columbus, Ohio, USA
November 9-10, 2018

2nd Annual Summit on Cell Therapy and Stem Cell Research

Atlanta, Georgia, USA
November 9-10, 2018

2nd Annual Summit on Cell Therapy and Regenerative Medicine

Atlanta, Georgia, USA
Dec 03-04, 2018

3rd World Biotechnology Congress

(10 Plenary Forums - 1Event)
Sao Paulo, Brazil

Molecular Farming Conference Speakers

Recommended Sessions

Related Journals

Are you interested in